News by subject: Business Update

Lobe Sciences Ltd. ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today provided an update from the Company on its progress and achievements in 2023. Philip Young CEO...

Viridian Therapeutics, Inc. , a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that President and Chief Executive Officer, Steve Mahoney, will discuss the...

Revance Therapeutics, Inc. today provided a corporate update as well as preliminary unaudited fourth quarter and full year 2023 financial results, 2024 guidance and financial outlook. A supplemental presentation can also be found on the company's...

bluebird bio, Inc. (the Company; bluebird) today announced updates to be presented at the 42nd Annual J.P. Morgan Healthcare conference including commercial launch progress, 2024 program milestones and financial outlook. Andrew Obenshain, chief...

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced Pascal...

Allurion Technologies, Inc. ("Allurion" or the "Company") , a company dedicated to ending obesity, today announced preliminary unaudited results for the fourth quarter and full year 2023. The Company also issued its preliminary 2024 outlook,...

Veracyte, Inc. , a leading cancer diagnostics company, today announced preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2023. The company also announced it has reached a definitive agreement to acquire...

GrowGeneration Corp. ("GrowGen" or the "Company"), the largest chain of specialty hydroponic and organic garden centers in the United States, today announced an update to its full-year 2023 financial outlook 2. The Company now expects revenue for...

Bayer today announced positive top-line results of the pivotal Phase III studies OASIS 1 and 2 evaluating the efficacy and safety of the investigational compound elinzanetant versus placebo. Elinzanetant successfully met all four primary endpoints in...

Lithium Royalty Corp. ("LRC" or the "Company") is pleased to report on the successful conclusion of its inaugural year as a public company, following its initial public offering in March 2023, with an update on key developments in 2023 through into...

Stoke Therapeutics, Inc. , a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced strategic priorities and anticipated milestones for 2024....

The National Bank of Coxsackie ("NBC"), the wholly-owned subsidiary of NBC Bancorp, Inc. , announced that in the fourth quarter of 2023, it sold $9 million in available-for-sale securities composed of US Treasury and municipal securities with a...

MarineMax, Inc. , the world's largest recreational boat, yacht and superyacht services company, today announced that it has entered into a definitive agreement to acquire Williams Tenders USA, Inc. The acquisition is expected to close by March 31,...

Mind Medicine (MindMed) Inc. , (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today provided a corporate update and outlook for 2024. "Our...

Schrödinger, Inc. , Schrödinger , whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today provided an update on its progress across the business and announced its development and operational...

Rockwell Medical, Inc. (the "Company") , a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company amended its loan and...

Organon today affirmed prior revenue and Adjusted EBITDA guidance, indicated that free cash flow before one-time spin-related costs is expected to be above the high end of the previous guidance range, and provided high-level financial objectives for...

Western Exploration Inc. (the "Company" or "Western Exploration") is pleased to announce final assay results and structural interpretation from the 2023 core drilling program in the Jarbidge rhyolite north-east of the Gravel Creek resource area at...

Eikon Therapeutics, Inc., a pioneering biotechnology company that leverages advanced engineering to enhance drug discovery and development, today announced that the company will provide an overview of clinical and preclinical progress in a...

PGT Innovations, Inc. ("PGTI" or the "Company"), a national leader in premium windows and doors, today announced that its Board of Directors has unanimously determined that, while the unsolicited proposal from Miter Brands to acquire all outstanding...

Nickel 28 Capital Corp. ("Nickel 28" or the "Company") is pleased to provide nickel and cobalt production levels for the Company's largest asset, being the Ramu Nickel-Cobalt ("Ramu") integrated operation in Papua New Guinea. Nickel 28 currently...

Orthofix Medical Inc. , a leading global spine and orthopedics company, today announced that effective immediately, Massimo Calafiore has assumed the role of President and Chief Executive Officer (CEO) and as a member of the Orthofix Board of...

Syros Pharmaceuticals , a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today highlighted anticipated 2024 milestones to deliver on the value of tamibarotene. "We are...

Armstrong World Industries, Inc. announced today that it has entered into a strategic partnership with McKinstry, a leading construction and energy services company, by making an equity investment in its Overcast Innovations venture. Overcast...

Papa John's International, Inc. ("Papa Johns®") today provided updates on long-term strategic initiatives designed to drive North America development, accelerate comparable sales growth and restaurant-level profitability in North America, as well as...

Repare Therapeutics Inc. ("Repare" or the "Company") , a leading clinical-stage precision oncology company, today provided a corporate update and highlighted key milestones anticipated in 2024. "We significantly advanced our pipeline in 2023 and...

Deciphera Pharmaceuticals, Inc. , a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today highlighted its strategic outlook for 2024 and planned...

NETSTREIT Corp. (the "Company") today provided an update on the Company's fourth quarter and full year 2023 business activities. "With the Company completing $431.0 million of net investment activity in 2023, we were pleased to meet our investment...

Genesco Inc. announced today that comparable sales, including both stores and direct sales, decreased by 4% for the quarter-to-date period ended December 30, 2023. Same store sales decreased 6% and sales for the Company's e-commerce businesses...

J.Jill, Inc. today reaffirmed its fourth quarter and full year 2023 guidance in advance of its presentation and investor meetings at the 26th Annual ICR Conference. For the fourth quarter of fiscal 2023, the Company continues to expect revenues to...

Sage Therapeutics, Inc. , a biopharmaceutical company leading the way to create a world with better brain health, today announced that Chief Executive Officer Barry Greene will discuss the Company's key business drivers for 2024 at the 42nd Annual...

Sage Therapeutics, Inc. , a biopharmaceutical company leading the way to create a world with better brain health, today announced the retirement of Kevin Starr from the company's board of directors. Geno Germano has assumed the role of Chair of the...

Wolverine World Wide, Inc. today, in advance of its presentation at the 2024 ICR Conference, provides an update on its preliminary, unaudited financial results for its fiscal year 2023, along with an update on its continuing transformation efforts....

Ironwood Pharmaceuticals, Inc. , a GI-focused healthcare company, today announced financial guidance for full year 2024. The results were announced in advance of the Company's presentation at the 42nd Annual J.P. Morgan Healthcare Conference, which...

TRG, a leading global managed solutions provider, proudly announces the launch of its invigorated brand and dynamic new website. As a privately owned powerhouse, TRG has been at the forefront of offering bold and innovative endpoint solutions for...

Aptia (the "Company"), a dedicated pension, health and benefits administration specialist, today announced its formal launch with 1,100 global clients to support more than 7 million people with health and wealth administration. Aptia was formed by...

Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today announced its preliminary* fourth quarter and full year 2023 global net product revenues for ONPATTRO, AMVUTTRA, GIVLAARI, and OXLUMO and provided additional updates on the...

Exelixis, Inc. today announced its preliminary unaudited financial results for the fiscal year 2023, provided financial guidance for fiscal year 2024 and delivered an update on its business. Exelixis expects 2024 to be a year of pipeline progress as...

Vertex Pharmaceuticals Incorporated today announced multiple program updates ahead of upcoming investor meetings in January, including the company's scheduled webcast from the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024...

Audacy, Inc., (the "Company" or "Audacy") today announced that it entered into a restructuring support agreement (the "RSA" or the "Agreement") with a supermajority of its debtholders on the terms of a comprehensive restructuring that will...

Agenus Inc. ("Agenus") , a leader in discovering and developing novel immunological agents to treat various cancers, today announced that the Compensation Committee of Agenus' Board of Directors granted, as of January 2, 2024 ("Grant Date"),...

JBT Corporation ("JBT"), a leading global technology solutions provider to high-value segments of the food & beverage industry, today announced that the Financial Supervisory Authority of the Central Bank of Iceland (the "FSA") has granted an...

Agilent Technologies Inc. today announced the company has again been included in the Dow Jones Sustainability World Index and the North America Index for its strong environmental, social, and governance (ESG) performance. "It's an honor to be...

Spark Networks SE ("Spark" or "the Company"), a leading social dating platform for meaningful relationships, today announced it received approval on its restructuring plan (the "Restructuring Plan") from the Local Court Charlottenburg, Berlin,...

Personalis, Inc. , a leader in advanced genomics for precision oncology, today reported unaudited preliminary revenue for the fourth quarter and full year ended December 31, 2023. Preliminary Fourth Quarter Revenue and Cash Balance Preliminary...

Virtus Investment Partners , which operates a multi-boutique asset management business, today announced that it is transferring the listing of its common stock to the New York Stock Exchange from the NASDAQ Global Select Market . Virtus...

Nodal Exchange announced today that it achieved record trading volumes in 2023 in both power and environmental markets. Nodal achieved a record 2.7 billion MWh power futures volume traded in 2023, representing 15% growth over 2022. Nodal is the...

ARC Gaming and Technologies, LLC f/k/a Lucky Bucks, LLC ("Lucky Bucks"), one of the largest Class B coin operated amusement machine ("COAM") route operators in Georgia, announced today it filed a lawsuit under the Racketeer Influenced and Corrupt...

Kiromic BioPharma, Inc. ("Kiromic" or the "Company"), a clinical-stage, fully-integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence and data mining platform to develop cell therapies with a focus on...

OneSpan Inc. ("OneSpan" or the "Company") today announced a leadership change designed to strengthen its strategic plan and accelerate the pace of execution of the Company's ongoing transformation. Victor Limongelli, a seasoned software CEO, has...